Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization
Chemical Biology & Drug Design · 2026-06 · 107 (6)
DOI: 10.1111/cbdd.70324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 31.05.2026. Verfasst von Batool Al-Lahowani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan. Hauptthemen laut MEDLINE: Antineoplastic Agents, Quinolones. Die Arbeit nennt 99 Literaturangaben. Gefördert von: Al-Zaytoonah University of Jordan.
Abstract (Originalsprache)
Cancer is a multifaceted disease that places a significant burden on healthcare systems and economies, driving the urgent need for novel therapeutic agents to curb its prevalence and impact. Thirty‐three analogues of N ‐substituted‐7‐and 8‐methyl‐4‐hydroxy‐2‐quinolone‐3‐carboxamides were synthesized and characterized using FT‐IR, NMR ( 1 H and 13 C), HRMS, and elemental analysis. The analogues displayed potential cytotoxicity against human colon cancer (HCT‐116) and epithelial colorectal adenocarcinoma (Caco‐2) cells. Compounds bearing a phenyl ring tailored with o ‐CF 3 ( 26 ) and a phenyl ring substituted with o ‐COOH and p ‐CH 3 ( 29 ) exert preferential inhibitory activity against HCT‐116 with IC 50s 9.4 and 7.8 μM. The bioinformatics calculations interpret the selectivity of analogues against HCT‐116. The principal component analysis (PCA) discloses that the analogues are regarded as lead‐like and nominated for hit‐to‐lead and lead optimization stages of drug discovery. Docking studies illustrate that analogues accommodate the kinase domain of PI3Kα and engage with key binding residues. The promising outcome of this work emphasizes the significance of this scaffold as anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman, Jordan.
- Department of Chemistry, The University of Jordan, Amman, Jordan.
- Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA.
- Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA.
ORCID-Profile: Rima Hajjo, Sanaa K Bardaweel, Dima A Sabbah
Förderung
- Al-Zaytoonah University of Jordan
Zitieren
APA
Al-Lahowani, B., Aswad, T. A., Hajjo, R., Islim, R. A., Bardaweel, S. K., Sweidan, K., Balaji, S., Tiwari, A. K., Abushaikha, G., & Sabbah, D. A. (2026). Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization. Chemical Biology & Drug Design, 107(6). https://doi.org/10.1111/cbdd.70324
Vancouver
Al-Lahowani B, Aswad TA, Hajjo R, Islim RA, Bardaweel SK, Sweidan K, et al. Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization. Chemical Biology & Drug Design. 2026;107(6). doi:10.1111/cbdd.70324
BibTeX
@article{AlLahowani2026,
author = {Al-Lahowani, Batool and Aswad, Tahrer Al-Bo and Hajjo, Rima and Islim, Reem A and Bardaweel, Sanaa K and Sweidan, Kamal and Balaji, Swapnaa and Tiwari, Amit K and Abushaikha, Ghassan and Sabbah, Dima A},
title = {Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {107},
number = {6},
doi = {10.1111/cbdd.70324}
}
EUVIMED